Michael Seckler
Vorstandsvorsitzender bei EVOME MEDICAL TECHNOLOGIES INC.
Vermögen: - $ am 31.05.2024
Profil
Michael D.
Seckler is currently the Chief Executive Officer & Director at Evome Medical Technologies, Inc., as well as a Director at GLyPharma Therapeutic, Inc. and K2 Biotechnology Ventures LLC.
Previously, he held the position of Vice President-Global Marketing at Ferring Pharmaceuticals, Inc. from 2017 to 2019.
He also served as the Chief Operating Officer at FerGene, Inc. from 2022 to 2023.
Mr. Seckler obtained his undergraduate degree and MBA from The Pennsylvania State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
14.06.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Michael Seckler
Unternehmen | Position | Beginn |
---|---|---|
EVOME MEDICAL TECHNOLOGIES INC. | Vorstandsvorsitzender | 13.06.2023 |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | - |
K2 Biotechnology Ventures LLC
K2 Biotechnology Ventures LLC Miscellaneous Commercial ServicesCommercial Services K2 Biotechnology Ventures LLC engages in accelerating the commercialization of university, medical center, and healthcare innovations. The private company is based in Chicago, IL. The company was founded by Kenneth B. Kashkin, Jane E. Kiernan. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Michael Seckler
Unternehmen | Position | Ende |
---|---|---|
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Geschäftsführer | 01.05.2023 |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Vertrieb & Marketing | 01.12.2019 |
Ausbildung von Michael Seckler
The Pennsylvania State University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EVOME MEDICAL TECHNOLOGIES INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
GLyPharma Therapeutic, Inc.
GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada. | Health Technology |
FerGene, Inc.
FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Health Technology |
K2 Biotechnology Ventures LLC
K2 Biotechnology Ventures LLC Miscellaneous Commercial ServicesCommercial Services K2 Biotechnology Ventures LLC engages in accelerating the commercialization of university, medical center, and healthcare innovations. The private company is based in Chicago, IL. The company was founded by Kenneth B. Kashkin, Jane E. Kiernan. | Commercial Services |